Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia-Reference-Cited by-同舟云学术

Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia

Published:2011-11 Issue:11 Volume:1 Page:e55-e55
ISSN:2158-3188
Container-title:Translational Psychiatry
language:en
Short-container-title:Transl Psychiatry

Author:

Tarabeux J, ,Kebir O,Gauthier J,Hamdan F F,Xiong L,Piton A,Spiegelman D,Henrion É,Millet B,Fathalli F,Joober R,Rapoport J L,DeLisi L E,Fombonne É,Mottron L,Forget-Dubois N,Boivin M,Michaud J L,Drapeau P,Lafrenière R G,Rouleau G A,Krebs M-O

Publisher

Springer Science and Business Media LLC

Subject

Biological Psychiatry,Cellular and Molecular Neuroscience,Psychiatry and Mental health

Link

http://www.nature.com/articles/tp201152.pdf

Reference61 articles.

1. Cull-Candy SG, Leszkiewicz DN . Role of distinct NMDA receptor subtypes at central synapses. Sci STKE 2004; 2004; re16.

2. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 1994; 51: 199–214.

3. Krystal JH, Anand A, Moghaddam B . Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia. Arch Gen Psychiatry 2002; 59: 663–664.

4. Amitai N, Markou A . Disruption of performance in the five-choice serial reaction time task induced by administration of N-methyl-D-aspartate receptor antagonists: relevance to cognitive dysfunction in schizophrenia. Biol Psychiatry 2010; 68: 5–16.

5. Vincent A, Bien CG . Anti-NMDA-receptor encephalitis: a cause of psychiatric, seizure, and movement disorders in young adults. Lancet Neurol 2008; 7: 1074–1075.

Cited by 198 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute and chronic excitotoxicity in ischemic stroke and late-onset Alzheimer’s disease;Neural Regeneration Research;2024-07-29

2. Characterization of Mice Carrying a Neurodevelopmental Disease-Associated GluN2B(L825V) Variant;The Journal of Neuroscience;2024-06-26

3. The NMDA receptor modulator zelquistinel durably relieves behavioral deficits in three mouse models of autism spectrum disorder;Neuropharmacology;2024-05

4. Central Causation of Autism/ASDs via Excessive [Ca2+]i Impacting Six Mechanisms Controlling Synaptogenesis during the Perinatal Period: The Role of Electromagnetic Fields and Chemicals and the NO/ONOO(-) Cycle, as Well as Specific Mutations;Brain Sciences;2024-04-30

5. NMDA Receptors in Health and Disease;Physiology;2024-04-02